Journal of Medical Systems

, Volume 32, Issue 2, pp 85–92 | Cite as

Optimization of Nanoparticle Drug Microcarrier on the Pharmacokinetics of Drug Release: A Preliminary Study

  • E. Y. K. Ng
  • W. K. Ng
  • S. S. Chiam
Original Paper


Ideal drug delivery process would exhibits zero-order kinetics. However, in practical, most drug delivery process is first-order kinetics. This study is aimed to mathematically model, analyze and determine the optimal polymer shape of the drug micro-carrier that achieves a near zero-order release. We also extend study in deriving and optimizing theoretically the optimal distance between the two optimal micro-carrier shapes. A mathematical model that derived from Carslaw and Jaeger equation of conduction of heat is used to model the relationship between the geometry shape of the carrier and the drug concentration. An optimization objective function is formulated from the mathematical model and MATLAB Optimization Toolbox is used to perform the numerical analysis. The results suggest that reducing the k value (ratio of volume of the fluid to that of the sphere) gives a near zero-order kinetics drug delivery response for all the microcarrier geometry shapes (with equivalent surface area/volume ratio to a sphere with radius R s ) investigated. Our preliminary results showed that tetrahedron microcarrier exhibits the best response and the worst response is for tablet (with R = R s /2).


Microcarrier Nanoparticles Optimization Pharmacokinetics MATLAB 



The first author would like to express his appreciation to Emeritus Professor W. J. Yang of University of Michigan, Ann Arbor, who shares his interests on this research topic.


  1. 1.
    Lindell, B. A. K., Nosslin, B., and Rothman, U., Studies in pharmacokinetics and tolerance of substances temporarily retained in the liver by microsphere embolization. Ann. Surg. 1:95, 1978.CrossRefGoogle Scholar
  2. 2.
    Ng, E. Y. K., and Ng, W. K., Analysis of nano-drug carriers towards optimum release rate. J. Med. Eng. Technol. 31(7):236–252, 2006.Google Scholar
  3. 3.
    Ozdemir, N., and Karatas, A., Effect of shape factor on the release rate of drugs from lipid matrices. Acta Pol. Pharm. 54:353–356, 1997.Google Scholar
  4. 4.
    Emerich, D. F., Snodgrass, P., Lafreniere, D., Dean, R. L., Salzberg, H., Marsh, J., Perdomo, B., Arastu, M., Winn, S. R., and Bartus, R. T., Sustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusions. Pharm. Res. 19(7):1052–1060, 2002.CrossRefGoogle Scholar
  5. 5.
    Davis, S. S., Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Trends Biotech. 15(6):217–224, 1997.CrossRefGoogle Scholar
  6. 6.
    Khairuzzaman, A., Ahmed, S. U., Savva, M., and Patel, N. K., Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets. Int. J. Pharm. 318(1–2):15–21, 2006.CrossRefGoogle Scholar
  7. 7.
    Landgraf, W., Li, N. H., and Benson, J. R., Polymer microcarrier exhibiting zero-order release. Drug Delivery Technology 3(1):1–12, 2003.Google Scholar
  8. 8.
    Liu, B. T., and Hsu, J. P., Inward release polymer matrix covered by a permeable membrane: a possible zero-order controlled release device. Chem. Eng. Sci. 60(21):5803–5808, 2005.CrossRefGoogle Scholar
  9. 9.
    Mazumdar, J., Pharmacokinetics: drug distribution in pharmacology, in an introduction to mathematical physiology & biology. Cambridge University Press: Cambridge, 1999, p. 90–108.Google Scholar
  10. 10.
    Rathbone, M., Hadgraft, J., and Roberts, M. S., Modified-release drug delivery technology, 1 ed. Marcel Dekker, Inc.: New York, 2003.Google Scholar
  11. 11.
    Saltzman, W., Drug delivery: engineering principles for drug therapy. Oxford University Press: Oxford, 2001.Google Scholar
  12. 12.
    Tzafriri, A., Lerner, E. I., Flashner-Barak, M., Hinchcliffe, M., Ratner, E., and Parnas, H., Mathematical modeling and optimization of drug delivery from intratumorally injection microspheres. Clin. Cancer Res. 11:826–834, 2005.Google Scholar
  13. 13.
    Wang, C. C., Tejwani, M. R., Roach, W. J., Kay, J. L., Yoo, J., Surprenant, H. L., Monkhouse, D. C., and Pryor, T. J., Development of near zero-order release dosage forms using three-dimensional printing (3-Dp (Tm)) technology. Drug Dev. Ind. Pharm. 32(3):367–376, 2006.CrossRefGoogle Scholar
  14. 14.
    Yang, W. J., Yang, P. P. T., and Miao, J. M., Some biomedical applications of nanotechnology-drug delivery, in international symposium on nanoscience & technology. Taiwan, 2003.Google Scholar
  15. 15.
    Siepmann, J., Kranz, H., Peppas, N. A., and Bodmeier, R., Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles. Int. J. Pharm. 201(2):151–164, 2000.CrossRefGoogle Scholar
  16. 16.
    Amidon, G. L., Sinko, P. J., and Fleisher, D., Estimating human oral fraction dose absorbed—a correlation using rat intestinal-membrane permeability for passive and carrier-mediated compounds. Pharm. Res. 5(10):651–654, 1988.CrossRefGoogle Scholar
  17. 17.
    Carslaw, H. S., and Jaeger, J. C., Conduction of heat in solids, 2 ed. Oxford University Press: Oxford, 1959.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.School of Mechanical and Aerospace Engineering, College of EngineeringNanyang Technological UniversitySingaporeSingapore
  2. 2.Office of Biomedical ResearchNational University Hospital (NUH) of SingaporeSingaporeSingapore

Personalised recommendations